ACE gene polymorphism and coronary restenosis

Area of Science:

• Cardiovascular Genetics
• Molecular Biology
• Medical Research

Background:

• Circulating angiotensin-converting enzyme (ACE) levels in humans are influenced by the ACE gene's insertion (I)/deletion (D) polymorphism.
• Individuals with the DD genotype exhibit higher ACE levels compared to those with ID or II genotypes.
• Previous research suggests a potential link between the ACE DD genotype and an increased risk of coronary artery disease.

Purpose of the Study:

• To review existing studies investigating the impact of the ACE I/D polymorphism on coronary restenosis.
• To explore the relationship between genetic variations in ACE and the development of neointimal hyperplasia after cardiovascular interventions.

Main Methods:

• Literature review of studies examining the ACE I/D polymorphism and coronary restenosis.
• Analysis of data concerning restenosis rates after balloon angioplasty versus coronary stent implantation in relation to ACE genotype.

Main Results:

• The ACE I/D polymorphism is not associated with restenosis following balloon angioplasty.
• A significant association exists between the ACE I/D polymorphism and restenosis after coronary stent implantation.
• Neointimal hyperplasia plays a more critical role in restenosis after stenting compared to balloon angioplasty.

Conclusions:

• The ACE I/D polymorphism's influence on coronary restenosis differs based on the intervention method.
• The findings suggest that the renin-angiotensin system's role in neointimal hyperplasia is particularly relevant in stent-mediated restenosis.